HomeAVH • ASX
AVITA Medical Inc
$4.95
Mar 28, 7:00:00 PM GMT+11 · AUD · ASX · Disclaimer
StockAU listed securityUS headquartered
Previous close
$4.92
Day range
$4.92 - $5.06
Year range
$2.88 - $6.27
Market cap
647.24M AUD
Avg Volume
183.11K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
14.20M50.13%
Operating expense
24.67M76.03%
Net income
-7.06M-31.98%
Net profit margin
-49.7712.10%
Earnings per share
-0.43-38.55%
EBITDA
-12.09M-109.17%
Effective tax rate
-0.17%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
89.06M12.24%
Total assets
111.64M13.61%
Total liabilities
62.58M362.76%
Total equity
49.06M
Shares outstanding
25.71M
Price to book
2.58
Return on assets
-31.85%
Return on capital
-39.04%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
-7.06M-31.98%
Cash from operations
-10.86M-216.15%
Cash from investing
-57.30M-1,714.57%
Cash from financing
39.43M4,286.21%
Net change in cash
-28.74M-408.51%
Free cash flow
-6.03M-264.49%
About
Avita Medical is a clinical and commercial company developing and marketing a range of respiratory and regenerative products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia. Wikipedia
Founded
1999
Employees
207
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu